Skip to content
Back to meeting Original
FirstWord Pharma· @fwpharma · X·· 18 hours agoScore45
Body

Roche's KRAS G12C inhibitor divarasib lives up to expectations in lung cancer study $RHHBY #ESMO2026 https://firstwordpharma.com/story/8267209

37 views · 0 likes · 0 reposts · 0 replies

Source: FirstWord Pharma · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org

Disclaimer CBA Frontier Insights uses AI-assisted methods to aggregate, summarize, and analyze publicly accessible biopharmaceutical information. Content is provided for informational and educational purposes only and does not represent the official views of original sources or affiliated organizations. AI-generated content may contain errors; please verify important information against primary sources. Intellectual property rights remain with their respective owners. For copyright concerns or corrections, please contact us through the website’s feedback page.